Skip to main content
. 2020 Aug 28;21:100860. doi: 10.1016/j.genrep.2020.100860

Table 1.

Summary of 54 FDA approved antiviral drugs selected for molecular docking studies.

Drugs Abbreviation PubChem ID Inhibitors class
Idoxuridine IDU 5905 5-Substituted 2′-deoxyuridine analogues
Trifluridine TFT 6256
Brivudine BVDU 446727
Vidarabine VDR 21704 Nucleoside analogues
Entecavir ETV 135398508
Telbivudine LdT 159269
Foscarnet PFA 3415 Pyrophosphate analogues
Zidovudine AZT 35370 Nucleoside reverse transcriptase (RT) inhibitors (NRTIs)
Didanosine ddI 135398739
Zalcitabine ddC 24066
Stavudine d4T 18283
Lamivudine 3TC 60825
Abacavir ABC 441300
Emtricitabine (−)FTC 60877
Nevirapine NVP 4463 Nonnucleoside reverse transcriptase inhibitors (NNRTIs)
Delavirdine DLV 5625
Efavirenz EFV 64139
Etravirine ETR 193962
Rilpivirine RPV 6451164
Saquinavir SQV 441243 Protease inhibitors
Ritonavir RTV 392622
Indinavir IDV 5362440
Nelfinavir NFV 64143
Amprenavir APV 65016
Atazanavir ATV 148192
Fosamprenavir FPV 131536
Tipranavir TPV 54682461
Darunavir DRV 213039
Telaprevir TVR 3010818
Boceprevir BOC 10324367
Simeprevir SMV 24873435
Asunaprevir ASV 16076883
Paritaprevir PTV 45110509
Grazoprevir GZR 44603531
Raltegravir RAL 54671008 Integrase inhibitors
Elvitegravir EVG 5277135
Dolutegravir DTG 54726191
Docosanol C22 12620 Entry inhibitors
Maraviroc MVC 3002977
Acyclovir ACV 135398513 Acyclic guanosine analogues
Ganciclovir GCV 135398740
Famciclovir FCV 3324
Valacyclovir VACV 135398742
Penciclovir PCV 135398748
Valganciclovir VGCV 135413535
Cidofovir CDV 60613 Acyclic nucleoside phosphonate analogues
Amantadine AMT 2130 Influenza virus inhibitors
Ribavirin RBV 37542
Rimantadine RIM 5071
Zanamivir ZAN 60855
Oseltamivir OTV 65028
Laninamivir octanoate LO 9847629
Peramivir PRV 154234
Favipiravir FPV 492405